Johnson & Johnson
JNJ
#24
Rank
A$790.90 B
Marketcap
A$328.56
Share price
-1.32%
Change (1 day)
38.83%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2026 (TTM): A$13.04

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is A$12.34. In 2025 the company made an earnings per share (EPS) of A$15.74 an increase over its 2024 EPS that were of A$9.45.

EPS history for Johnson & Johnson from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$13.04-17.12%
2025A$15.7466.46%
2024A$9.45-53.6%
2023A$20.38111.16%
2022A$9.65-13.84%
2021A$11.2041.81%
2020A$7.90-18.92%
2019A$9.7421.2%
2018A$8.041125.3%
2017A$0.66-92.23%
2016A$8.447.37%
2015A$7.86-4.16%
2014A$8.2018.1%
2013A$6.9424.88%
2012A$5.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$9.92-19.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.85-85.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.10-58.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$5.07-58.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$39.88 223.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.62-70.70%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
A$9.68-21.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
A$12.00-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$5.03-59.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.49-55.52%๐Ÿ‡ฌ๐Ÿ‡ง UK